• Report

Model to estimate costs of using labeling as a risk reduction strategy for consumer products regulated by the Food and Drug Administration. Contract No. GS-10F-0097L, Task Order 5. Revised final report

Citation

Muth, M., Ball, M., Coglaiti, M., & Karns, S. (2012). Model to estimate costs of using labeling as a risk reduction strategy for consumer products regulated by the Food and Drug Administration. Contract No. GS-10F-0097L, Task Order 5. Revised final report. (Prepared for U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition). Research Triangle Park, NC: RTI International.

Abstract

In September 2009, the U.S. Food and Drug Administration (FDA) contracted with RTI International to provide support to economics staff in FDA’s Center for Food Safety and Applied Nutrition (CFSAN) and FDA’s Office of the Commissioner (OC) by providing a tool to estimate the costs of risk-reduction strategies that include product labeling changes.
The 2010 FDA Labeling Cost Model is programmed in Microsoft Excel 2003 with a Visual Basic interface that steps the user through the selection of the model inputs. The model outputs are provided in an Excel spreadsheet, allowing users to easily tailor the results for each specific use. The product types included in the model are as follows:
- cosmetics
- dietary supplements
- foods
- over-the-counter (OTC) medications
- pet foods
- retail medical devices
- tobacco products and accessories.